Valuation: ANGLE plc

Capitalization 23.31M 31.63M 27.39M 25.66M 42.98M 2.72B 48.77M 300M 117M 1.25B 119M 116M 4.56B P/E ratio 2025 *
-1.43x
P/E ratio 2026 * -1.85x
Enterprise value 24.23M 32.88M 28.47M 26.67M 44.67M 2.83B 50.69M 312M 122M 1.3B 123M 121M 4.74B EV / Sales 2025 *
2.86x
EV / Sales 2026 * 1.73x
Free-Float
83.82%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+3.57%
1 week+3.57%
Current month-9.38%
1 month-6.45%
3 months-21.20%
6 months-34.09%
Current year-29.27%
More quotes
1 week 6.5
Extreme 6.5
7.5
1 month 6.5
Extreme 6.5
11.44
Current year 6.5
Extreme 6.5
17.44
1 year 6.5
Extreme 6.5
17.44
3 years 6.5
Extreme 6.5
106.85
5 years 6.5
Extreme 6.5
163.75
10 years 6.5
Extreme 6.5
163.75
More quotes
Manager TitleAgeSince
Chief Executive Officer 64 31/03/1994
Director of Finance/CFO - 31/12/1994
Chief Tech/Sci/R&D Officer - 04/06/2023
Director TitleAgeSince
Director/Board Member 64 14/11/2010
Chairman - 14/11/2010
Director/Board Member 81 06/01/2013
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+3.57%+3.57%-49.12%-93.00% 31.69M
-1.11%+0.05%-14.76%-37.89% 14.9B
-3.28%-2.13%-22.56%-69.38% 1.95B
-2.79%-6.03%-18.86% - 1.23B
-2.35%-3.61%-40.39%+163.11% 1.22B
+0.07%+0.14%-18.00%-19.93% 1.2B
-0.53%-5.65%+1.87%-2.12% 989M
-1.79%-4.53%-2.21%-38.15% 843M
-2.04%-1.07%-2.66%-49.23% 779M
-3.91%-3.71%-26.31%-45.14% 470M
Average -1.42%-2.78%-19.30%-21.30% 2.36B
Weighted average by Cap. -1.46%-1.34%-15.84%-27.80%
See all sector performances

Financials

2025 *2026 *
Net sales 8.49M 11.51M 9.97M 9.34M 15.64M 991M 17.75M 109M 42.55M 454M 43.2M 42.29M 1.66B 16.6M 22.53M 19.51M 18.27M 30.61M 1.94B 34.74M 214M 83.27M 888M 84.54M 82.76M 3.25B
Net income -14.62M -19.84M -17.18M -16.09M -26.96M -1.71B -30.59M -188M -73.32M -782M -74.44M -72.87M -2.86B -11.69M -15.86M -13.73M -12.86M -21.55M -1.37B -24.45M -150M -58.61M -625M -59.51M -58.25M -2.29B
Net Debt 918K 1.25M 1.08M 1.01M 1.69M 107M 1.92M 11.82M 4.61M 49.14M 4.68M 4.58M 180M 5.47M 7.43M 6.43M 6.02M 10.09M 639M 11.45M 70.46M 27.45M 293M 27.87M 27.28M 1.07B
More financial data * Estimated data
Logo ANGLE plc
ANGLE plc is a United Kingdom-based liquid biopsy company with circulating tumor cell (CTC) solutions for use in research, drug development and clinical oncology using a simple blood sample. Its circulating tumor cell (CTC) harvesting technology known as the Parsortix PC1 System enables complete downstream analysis of the sample, including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis. The Parsortix PC1 system is a medical device for the capture and harvest of intact CTCs from metastatic breast cancer (MBC) patient blood for user-validated analysis. Its commercial businesses focus on diagnostic products and clinical services. Its diagnostic products include the Parsortix system and associated consumables. Its services include custom made assay development and clinical trial testing for pharma. The Parsortix technology uses a microfluidic technology in the form of a single use cassette to capture and then harvest CTCs from whole blood.
Employees
119
More about the company
Date Price Change Volume
13/06/25 7.250 p +3.57% 486,169
12/06/25 7.000 p 0.00% 801,702
11/06/25 7.000 p -3.45% 922,510
10/06/25 7.250 p +3.57% 1,062,063
09/06/25 7.000 p 0.00% 1,101,019

Delayed Quote London S.E., June 13, 2025 at 04:35 pm

More quotes
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0725GBP
Average target price
0.3350GBP
Spread / Average Target
+362.07%
Consensus

Annual profits - Rate of surprise